Lactoferrin in gastrointestinal disease

Internal Medicine

Volumn 48, Issue 15, 2009, Pages 1251-1254

  Hayakawa, Tetsuo ^a   Jin, Chun Xiang ^b   Ko, Shigeru B H ^c   Kitagawa, Motoji ^d   Ishiguro, Hiroshi ^c  

^a Meijo Hospital   (Japan)

^b JILIN UNIVERSITY   (China)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY OF ARTS AND SCIENCES   (Japan)

Author keywords

Anti lactoferrin antibody; Autoimmune liver disease; Autoimmune pancreatitis; Chronic pancreatitis; Iinflammatory bowel disease; Lactoferrin

Indexed keywords

BIOLOGICAL MARKER; LACTOFERRIN; LACTOFERRIN AUTOANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ASCITES; ASCITES FLUID; AUTOIMMUNE PANCREATITIS; BACTERIAL PERITONITIS; CHRONIC PANCREATITIS; CLINICAL FEATURE; DIAGNOSTIC VALUE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE MARKER; ENTERITIS; FECES ANALYSIS; FECES COMPOSITION; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOPATHOGENESIS; IRRITABLE COLON; PANCREAS JUICE; PANCREAS STONE; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY;

ASCITIC FLUID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CALCULI; CARRIER PROTEINS; FECES; GASTROINTESTINAL DISEASES; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME; LACTOFERRIN; PANCREATIC JUICE;

EID: 70349527599     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2199     Document Type: Review

References (35)

1. Masson PL, Heremans JF. Studies on lactoferrin, the iron biding protein of secretions. Protides Biol Fluid 14: 115-124, 1966.
2. Martins CA, Fonteles MG, Barrett LJ, Guerrant RL. Correlation of lactoferrin with neutrophilic inflammation in body fluids. Clin Diagn Lab Immunol 2: 763-765, 1995.
3. Rado TA, Bollekens J, St Laurent G, Parker L, Benz EJ Jr. Lactoferrin biosynthesis during granulocytopoiesis. Blood 64: 1103-1109, 1984.
4. Guerrant RL, Araujo V, Soares E, et al. Measurement of fecal lactoferrin as a marker of fecal leucocytes. J Clin Microbiol 30: 1238-1242, 1992.
5. Parsi M, Saadeh SN, Zein NN, et al. Ascites fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis. Gastroenterology 135: 803-807, 2008.
6. Sugiyama T, Tsuchida M, Yokota K, Shimodan M, Asaka M. Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection. Intern Med 41: 491-494, 2002.
7. Yoshihara M, Hirai M, Tanaka N, Kasahara Y, Hosokawa O. Remission of severe anemia persisting for over 20 years after eradication of Helicobacter pylori in cases of Ménètrier's disease and atrophic gastritis: Helicobacter pylori as a pathogenic factor in iron-deficiency anemia. Intern Med 42: 971-977, 2003.
8. Nakata H, Ichinose M. Helicobacter pylori and iron deficiency anemia. Intern Med 42: 922, 2003.
9. Luqmani YA, Campbell TA, Bennett C, Coombes RC, Paterson IM. Expression of lactoferrin in human stomach. Int J Cancer 49: 684-687, 1991.
10. Dhaenens L, Szczebara F, Husson MO. Identification, characterization, and immunogenicity of the lactoferrin-binding protein from Helicobacter pylori. Infect Immun 65: 514-518, 1997.
11. Bennett RM, Eddie-Quartey AC, Holt PJ. Lactoferrin - an iron binding protein in synovial fluid. Arthritis Rheum 16: 186-190, 1973.
12. Dai J, Liu WZ, Zhao YP, Hu YB, Ge ZZ. Relationship between fecal lactoferrin and inflammatory bowel disease. Scand J Gastroenterol 42: 1440-1444, 2007.
13. Schoepfer AM, Trummler M, Seeholzer P, Cribles DH, Seibold F. Accuracy of four fecal assays in the diagnosis of colitis. Dis Colon Rectum 50: 1697-1706, 2007.
14. Ashraf H, Beltinger J, Alam NH, et al. Evaluation of fecal occult blood test and lactoferrin latex agglutination test in screening hospitalized patients for diagnosis inflammatory and noninflammatory diarrhea in Dhaka, Bangladesh. Digestion 76: 256-261, 2007.
15. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 98: 1309-1314, 2003.
16. Langhorst J, Elsenbruch S, Mueller T, et al. Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm Bowel Dis 11: 1085-1091, 2005.
17. Schrd̈er O, Naumann M, Shastri Y, Povse N, Stein J. Prospective evaluation of fecal neutrophils-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin. Aliment Pharmacol Ther 26: 1035-1042, 2007.
18. Sipponen T, Savilahti E, Kr̈kkäinen P, et al. Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNFalpha therapy for Crohn's disease. Inflamm Bowel Dis 14: 1392-1398, 2008.
19. Otten CM, Koh L, Witteman BJ, et al. Diagnostic performance of rapid tests for dection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. Clin Chem Lab Med 46: 1275-1280, 2008.
20. Langhorst J, Elsenbruch S, Koelzer J, et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel disease: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 108: 162-169, 2008.
21. Sutherland AD, Geary RB, Frizelle FA. Review of fecal biomarkers in inflammatory bowel disease. Dis Colon Rectum 51: 1283-1291, 2008.
22. Parsi MA, Shen BO, Ackkan JP, et al. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology 126: 1280-1286, 2004.
23. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 32: 142-153, 2000.
24. Garcia-Tsao G. Current management of the complication of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 120: 726-748, 2001.
25. Hekman A. Association of lactoferrin with other protein, as demonstrated by changes in eletrophoretic mobility. Biochem Biophys Acta 251: 380-387, 1971.
26. Figarella C, Sarles H. Lactoferrin, a protein of human pancreatic external secretion. Scand J Gactroenterol 10: 449-451, 1975.
27. Multinger L, Figarella C, Sahel J, Sarles H. Lactoferrin and albumin in human pancreatic juice. Dig Dis Sci 25: 173-178, 1980.
28. Jin CX, Naruse S, Kitagawa M, et al. Pancreatic stone protein of pancreatic calculi in chronic calcified pancreatitis in man. JOP J Pancreas 3: 54-61, 2002.
29. Nagai H, Ohtsubo K. Pancreatic lithiasis in the aged. Its clinicopathology and pathogenesis. Gastroenterology 86: 331-338, 1964.
30. Muratori L, Muratori P, Zauli D, et al. Antilactoferrin antibodies in autoimmune liver disease. Clin Exp Immunol 124: 470-473, 2001.
31. Ohana M, Okazaki K, Hajiro K, Uchida K. Antilactoferrin antibodies in autoimmune liver disease. Am J Gastroenterol 93: 1334-1339, 1998.
32. Jin CX, Hayakawa T, Kitagawa M, Ishiguro H. Lactoferrin in chronic pancreatitis. JOP J Pancreas 10: 237-241, 2009.
33. Okazaki K. Autoimmune pancreatitis: Etiology, pathogenesis, clinical findings and treatment. The Japanese experience. JOP J Pancreas 6: 89-96, 2005.
34. Hardt PD, Ewald N, Brokling K, et al. Distinct autoantibodies against exocrine pancreatic antigens in European patients with type I diabetes mellitus and non-alcoholic chronic pancreatitis. JOP J Pancreas 9: 683-689, 2008.
35. Taniguchi T, Okazaki K, Okamoto M, et al. High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in type I diabetes: Concept of the pancreas. Pancreas 27: 26-30, 2003.